Journal
JOURNAL OF NEUROGENETICS
Volume 30, Issue 1, Pages 5-15Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/01677063.2016.1144751
Keywords
Addiction; attention deficit hyperactivity disorder; dopamine transporter; knockout; Parkinson's disease; schizophrenia
Categories
Funding
- Russian Science Foundation grant [14-15-00131]
- NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022449] Funding Source: NIH RePORTER
- Russian Science Foundation [14-15-00131] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
The dopamine transporter (DAT) plays an important homeostatic role in the control of both the extracellular and intraneuronal concentrations of dopamine, thereby providing effective control over activity of dopaminergic transmission. Since brain dopamine is known to be involved in numerous neuropsychiatric disorders, investigations using mice with genetically altered DAT function and thus intensity of dopamine-mediated signaling have provided numerous insights into the pathology of these disorders and novel pathological mechanisms that could be targeted to provide new therapeutic approaches for these disorders. In this brief overview, we discuss recent investigations involving animals with genetically altered DAT function, particularly focusing on translational studies providing new insights into pathology and pharmacology of dopamine-related disorders. Perspective applications of these and newly developed models of DAT dysfunction are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available